Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis

Cherrie-Lee N Small, Sarah A Reid-Yu, Joseph B McPhee, Brian K Coombes, Cherrie-Lee N Small, Sarah A Reid-Yu, Joseph B McPhee, Brian K Coombes

Abstract

Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract in which alterations to the bacterial community contribute to disease. Adherent-invasive Escherichia coli are associated with human Crohn's disease; however, their role in intestinal immunopathology is unclear because of the lack of an animal model compatible with chronic timescales. Here we establish chronic adherent-invasive Escherichia coli infection in streptomycin-treated conventional mice (CD1, DBA/2, C3H, 129e and C57BL/6), enabling the study of host response and immunopathology. Adherent-invasive Escherichia coli induces an active T-helper 17 response, heightened levels of proinflammatory cytokines and fibrotic growth factors, with transmural inflammation and fibrosis. Depletion of CD8+ T cells increases caecal bacterial load, pathology and intestinal fibrosis in C57BL/6 mice, suggesting a protective role. Our findings provide evidence that chronic adherent-invasive Escherichia coli infections result in immunopathology similar to that seen in Crohn's disease. With this model, research into the host and bacterial genetics associated with adherent-invasive Escherichia coli-induced disease becomes more widely accessible.

Conflict of interest statement

Competing Financial Interests

The authors declare no competing financial interests.

Figures

Figure 1. Competitive infection between AIEC strain…
Figure 1. Competitive infection between AIEC strain LF82 and NRG857c and NRG857c localization in the cecum of CD1 mice
a. Mice were infected with an equal mixture of AIEC strains LF82 and NRG857c and individual AIEC populations were enumerated in fecal output. Each data point represents the competitive index (CI) from an individual animal. Solid lines indicate the geometric mean for each group (n=5). b. Quantification of AIEC in feces of monocolonized mice. * P<0.05; **P<0.01 (Mann-Whitney). Data are means with standard error from 4–9 mice per group from two experiments. c. Immunohistochemistry of cecal sections 28 days after infection with NRG857c and in PBS controls. Tissue was fixed and processed for immunohistochemical staining using an antibody directed against the O83 antigen found on AIEC strain NRG857c (brown stain in images). Images are representative from two separate experiments.
Figure 2. Bacterial load of AIEC in…
Figure 2. Bacterial load of AIEC in various mouse strains
Groups of conventional mice; a. CD1, b. DBA/2, c. 129e, d. C3H and e. C57BL/6 were infected with AIEC NRG857c and organs were harvested following infection. Data are expressed as the means with standard error of four mice per time point and representing two independent experiments. *P <0.05, ** P <0.001 (one-way ANOVA with Tukey post-test) for comparisons between the time points indicated by bars.
Figure 3. Inflammation and tissue pathology in…
Figure 3. Inflammation and tissue pathology in the cecum following chronic infection with AIEC
a. H&E staining of cecal sections from CD1, DBA/2, 129e, C3H and C57BL/6 mice after AIEC infection and from uninfected controls. Images are representative of two experiments with four mice per time point. MM, muscularis mucosa; SM, submucosa; M, mucosa; L, lumen. Arrows indicate submucosa edema, desquamation, hyperplasia, inflammatory cellular infiltrates and epithelial sloughing. b. Cecal pathology was scored 3 weeks after infection. Scores represent an average of 5 views per section and data are expressed as the means with SD for each group. Original magnification: 200x; scale bar: 200 μm.
Figure 4. Th1 and Th17 inflammatory responses…
Figure 4. Th1 and Th17 inflammatory responses in the colon and cecum following chronic AIEC infection
The colon and cecum from groups of mice were removed and processed. a. TNF-α, b. IFN-γ, c. IL-17 and d. MCP1 were measured from the colon (left panels) and cecum (right panels) by ELISA. Data are the mean with standard error from four mice per group and from two independent experiments. *P <.05, **P <.01, *** P <.001 (compared to uninfected controls; one-way ANOVA with Dunnett post-test).
Figure 5. Intestinal fibrosis in the cecum…
Figure 5. Intestinal fibrosis in the cecum following chronic AIEC infection
Masson’s trichrome and PSR staining of cecal tissue from a. CD1, b. DBA/2, and c. C57BL/6 mice following AIEC infection and from uninfected controls. Black arrows in the Masson’s trichrome panels indicate collagen deposition (green) in the submucosa and the mucosa surrounding inflammatory cellular infiltrates. White arrows in the PSR panels indicate collagen fibrils (large collagen fibers, yellow/orange; thinner fibers, green) in the muscularis mucosa, submucosa and mucosa. MM, muscularis mucosa; SM, submucosa; M, mucosa. Images are representative of two experiments with four mice per time point. Original magnification: 200x; scale bar: 200 μm.
Figure 6. Profibrotic mediators associated with AIEC-induced…
Figure 6. Profibrotic mediators associated with AIEC-induced fibrosis
The mRNA levels of a. TGF-β1, b. CTGF and c. IGF1 expression in the colon (upper panels) and cecum (lower panels) was determined three weeks post-AIEC infection. Data is normalized to 18s RNA and expressed as fold-change relative to the uninfected control. Quantification of d. collagen type I (Col1a2) and e. collagen type III (Col3a1) was determined by qRT-PCR. Data was normalized to 18s RNA and expressed as fold-change relative to the uninfected PBS-treated control. Data are expressed as the means with standard error from four mice per group representative of two independent experiments. *P <0.05, **P<0.005, *** P <0.001 compared to uninfected PBS-treated controls (one-way ANOVA with Dunnett post-test).
Figure 7. Intestinal pathology is associated with…
Figure 7. Intestinal pathology is associated with increased numbers of immune cells during chronic AIEC infection
Formalin-fixed sections from C57BL/6 mice infected with NRG857c for 21 days were IHC stained for a. F4/80, b. Foxp3 and c. CD3. Each image is representative of 3 mice per experiment and quantification represent an average of 6–8 views per section. Scale bar: 200 μm.
Figure 8. CD8+ immune cells are protective…
Figure 8. CD8+ immune cells are protective role during chronic AIEC infection
a. Rag1−/−, CD4-, CD8-depleted, and IgG control mice were infected with NRG857c (3 mice per group, experiment repeated twice). AIEC load in fecal pellets was quantified from immune-depleted mice over time. At day 21, cecal tips were scored for histopathology (b) on H&E-stained sections (c) scale bar: 50 μm. d. Cecal sections were stained with PSR for quantification of fibrosis. Original magnification, 200x. e. Cytokines were measured from cecal explant supernatants by ELISA. C57BL/6 mice were infected with NRG857c or mock infected with PBS (3 mice per group were pooled, and experiment was repeated 3 times), and at day 21 after infection the cecum was excised and lamina propria immune cells were isolated and stained for FACS analysis. f. Percentage of CD45.2+ CD8+ lymphocytes measured by flow cytometry of lamina propria cells from AIEC-infected C57BL/6 mice (day 21). g. The number of CD8+ IFNγ+ lamina propria cells measured by flow cytometry expressed as a percentage of the PBS control. Data are the means with standard error. *P<0.05 (student t-test).

References

    1. Henderson P, van Limbergen JE, Wilson DC, Satsangi J, Russell RK. Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:346–361.
    1. Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.
    1. Benchimol EI, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423–439.
    1. Ruemmele FM. Pediatric inflammatory bowel diseases: coming of age. Curr Opin Gastroenterol. 2010;26:332–336.
    1. Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn’s disease. Ann Rev Genomics Hum Genetics. 2009;10:89–116.
    1. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756–1767.
    1. Franke A, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–1125.
    1. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306.
    1. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564–577.
    1. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594.
    1. Manichanh C, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205–211.
    1. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn’s disease and ulcerative colitis patients. J Med Microbiol. 2006;55:1141–1149.
    1. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591–3596.
    1. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38.
    1. Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn’s disease. Curr Opin Gastroenterol. 2007;23:16–20.
    1. Darfeuille-Michaud A, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–421.
    1. Nash JH, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.
    1. Miquel S, et al. Complete genome sequence of Crohn’s disease-associated adherent-invasive E. coli strain LF82. PLoS ONE. 2010;5:e12714.
    1. Krause DO, Little AC, Dowd SE, Bernstein CN. Complete genome sequence of adherent invasive Escherichia coli UM146 isolated from Ileal Crohn’s disease biopsy tissue. J Bacteriol. 2011;193:583.
    1. Darfeuille-Michaud A, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology. 1998;115:1405–1413.
    1. Carvalho FA, et al. Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009;206:2179–2189.
    1. Sarra M, et al. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis. 2010;16:1332–1339.
    1. Holtta V, et al. IL-23/IL-17 immunity as a hallmark of Crohn’s disease. Inflamm Bowel Dis. 2008;14:1175–1184.
    1. Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768–780.
    1. Motomura Y, et al. Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. Gut. 2006;55:662–670.
    1. Burke JP, et al. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn’s disease. Inflamm Bowel Dis. 2008;14:1197–1204.
    1. Lawrance IC, et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology. 2003;125:1750–1761.
    1. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol. 2000;279:G653–659.
    1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390–407.
    1. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1720–1728.
    1. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis. 2009;22:292–301.
    1. Drouet M, et al. AIEC colonization and pathogenicity: Influence of previous antibiotic treatment and preexisting inflammation. Inflamm Bowel Dis. 2012;18:1923–1931.
    1. Fichtner-Feigl S, et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol. 2007;178:5859–5870.
    1. Li Z, et al. Small intestinal intraepithelial lymphocytes expressing CD8 and T cell receptor gammadelta are involved in bacterial clearance during Salmonella enterica serovar Typhimurium infection. Infect Immun. 2012;80:565–574.
    1. Nomura A, et al. The role of gammadelta T cells in induction of bacterial antigen- specific protective CD8+ cytotoxic T cells in immune response against the intracellular bacteria Listeria monocytogenes. Immunology. 1998;95:226–233.
    1. Reikvam DH, et al. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn’s disease patients. Scand J Gastroenterol. 2011;46:550–560.
    1. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011;140:957–965.
    1. Di Sabatino A, et al. Peripheral regulatory T cells and serum transforming growth factor-beta: relationship with clinical response to infliximab in Crohn’s disease. Inflamm Bowel Dis. 2010;16:1891–1897.
    1. Graham MF, et al. Collagen content and types in the intestinal strictures of Crohn’s disease. Gastroenterology. 1988;94:257–265.
    1. Burke JP, et al. Fibrogenesis in Crohn’s disease. Am J Gastroenterol. 2007;102:439–448.
    1. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn’s disease. Gastroenterology. 1992;102:1920–1929.
    1. Eaves-Pyles T, et al. Escherichia coli isolated from a Crohn’s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397–409.
    1. Coburn B, Li Y, Owen D, Vallance BA, Finlay BB. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun. 2005;73:3219–3227.
    1. Hadi AM, et al. Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncology. 2011;34:343–354.

Source: PubMed

3
Předplatit